Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Vertex Pharmaceuticals Incorporated Company Profile (NASDAQ:VRTX)

Consensus Ratings for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (?)
Ratings Breakdown: 8 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Hold (Score: 2.47)
Consensus Price Target: $103.27 (7.86% upside)

Current Analysts' Coverage Summary for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/9/2014TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
7/8/2014ZacksReiterated RatingNeutral -> Neutral$102.00ViewTweet This Rating  Share This Rating on StockTwits
7/7/2014OppenheimerDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
6/25/2014Goldman SachsBoost Price Target$109.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014Citigroup Inc.Reiterated RatingBuy$103.00 -> $136.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014Sanford C. BernsteinBoost Price Target$65.00 -> $107.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014Leerink SwannBoost Price TargetOutperform$100.00 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014HC WainwrightDowngradeBuy -> Neutral$105.00 -> $85.00ViewTweet This Rating  Share This Rating on StockTwits
6/24/2014Needham & Company LLCBoost Price TargetPositive -> Buy$95.00 -> $115.00ViewTweet This Rating  Share This Rating on StockTwits
6/24/2014Deutsche BankReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/24/2014Maxim GroupBoost Price TargetBuy$92.00 -> $107.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
10/30/2013Credit SuisseLower Price TargetNeutral$80.00 -> $78.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013Summer StreetDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
10/29/2013Cowen and CompanyLower Price TargetNeutral$87.94 -> $80.00ViewTweet This Rating  Share This Rating on StockTwits
10/29/2013Wells Fargo & Co.Reiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
10/16/2013BarclaysLower Price TargetOverweight$95.00 -> $92.00ViewTweet This Rating  Share This Rating on StockTwits
7/23/2013William BlairBoost Price Target$83.00 -> $94.00ViewTweet This Rating  Share This Rating on StockTwits
4/22/2013S&P Equity ResearchBoost Price TargetBuy$60.00 -> $100.00ViewTweet This Rating  Share This Rating on StockTwits
4/19/2013Robert W. BairdBoost Price TargetOutperform$53.00 -> $88.00ViewTweet This Rating  Share This Rating on StockTwits
4/19/2013RBC CapitalBoost Price TargetOutperform$70.00 -> $95.00ViewTweet This Rating  Share This Rating on StockTwits
4/19/2013Chardan CapitalBoost Price TargetBuy$80.00 -> $105.00ViewTweet This Rating  Share This Rating on StockTwits
4/19/2013Canaccord GenuityUpgradeHold -> Buy$55.00 -> $96.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2013JPMorgan Chase & Co.Reiterated RatingOverweight$82.00 -> $86.00ViewTweet This Rating  Share This Rating on StockTwits
1/15/2013Lazard LtdDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Janney Montgomery ScottInitiated CoverageBuy$54.00ViewTweet This Rating  Share This Rating on StockTwits
11/28/2012ArgusDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/2/2012Brean CapitalReiterated RatingBuy$69.00ViewTweet This Rating  Share This Rating on StockTwits
8/30/2012ThinkEquityInitiated CoverageBuy$64.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2012Bank of AmericaLower Price Target$71.00 -> $66.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2012Piper JaffrayDowngradeOverweight -> Neutral$75.00 -> $57.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2012 forward)